TABLE 3.
Adjusted Odds Ratios (99% Confidence Intervals) Comparing the Receipt of Preventive Services Among Patients Enrolled in PCMHs and Not Enrolled in These Programs Using Propensity Score Matching, Regression Adjustment, and 1:1 Matching on Patient Demographics
| Outcome | Propensity Score Matching | Regression Adjustmenta | 1:1 Matching |
|---|---|---|---|
| Preventive visits | 1.10 (0.93–1.29) | 1.28 (1.10–1.49) | 1.40 (0.80–2.44) |
| Influenza vaccinationb | 0.89 (0.74–1.07) | 1.11 (0.94–1.31) | 1.04 (0.54–2.00) |
| Meningococcal vaccinationb | 1.53 (1.30–1.80) | 1.74 (1.46–2.08) | 1.88 (1.08–3.28) |
| HPV vaccinationb | 1.53 (1.28–1.84) | 1.77 (1.49–2.10) | 2.54 (1.36–4.73) |
| STI screeningb | 1.69 (1.28–2.24) | 2.07 (1.66–2.56) | 2.30 (0.91–5.84) |
| Contraception prescriptionb | 2.18 (1.56–3.03) | 3.39 (2.50–4.61) | 5.00 (1.54–16.20) |
| LARC prescriptionb | 2.66 (1.89–3.74) | 3.96 (2.86–5.49) | 7.83 (2.15–28.51) |
| Cervical cancer screeningb | 1.14 (0.87–1.48) | 1.20 (0.93–1.56) | 0.69 (0.22–2.17) |
Analyses evaluating contraceptive prescriptions and cervical cancer screening were conducted only among female patients. The analysis of cervical cancer screening was also restricted to patients aged 21 y or older.
a
Mixed effect regression models were adjusted for patient’s gender, age, race, country of birth, primary language spoken at home, marital, employment, and health insurance status.
b
These items had consistent findings across analytical methods.